Three New Media Briefings Added To BIO's CEO & Investor ConferenceFeb 21 2003
WASHINGTON, D.C. (February 21, 2003) - Three groups of industry experts will hold press briefings during the Biotechnology Industry Organization’s (BIO) CEO & Investor Conference, February 25-27 at... |
|
Final Day of Advance Media Registration for BIO’s CEO & Investor Conference 2003Feb 14 2003
WASHINGTON, D.C. (February 14, 2003) – Today is the deadline for advance media registration for the Biotechnology Industry Organization’s (BIO) CEO & Investor Conference 2003, February 25-27 at the... |
|
BIO Statement on the Death of Dolly, the Cloned SheepFeb 14 2003
WASHINGTON, D.C. (February 14, 2003) - Carl B. Feldbaum, President of the Biotechnology Industry... |
|
James D. Watson Helix 2003 Award to be Presented at BIO CEO and Investor ConferenceFeb 12 2003
WASHINGTON, D.C. (February 12, 2003) --- In recognition of biotechnology corporate excellence, the eighth annual Helix Award will be presented to three deserving companies on Feb. 27 at the... |
|
Industry Experts on Drug Development and Genetic Testing Announced for BIO’s CEO & Investor ConferenceFeb 11 2003
WASHINGTON, D.C. (February 11, 2003)—The Biotechnology Industry Organization (BIO) today announced an array of industry experts that will discuss the future of the biotech investment landscape... |
|
BIO Statement: Anti-Cloning Bill Deserves SupportFeb 5 2003
Washington, D.C. (February 5, 2003) - Michael Werner, vice president for bioethics at the Biotechnology Industry Organization (BIO), today issued the following statement on the introduction of the... |
|
BIO Statement: Anti-Cloning Bill Deserves SupportFeb 5 2003
Washington, D.C. (February 5, 2003) - Michael Werner, vice president for bioethics at the Biotechnology Industry Organization (BIO), today issued the following statement on the introduction of the... |
|
BIO’s CEO Conference Highlights Economic Potential of Biotech IndustryFeb 4 2003
WASHINGTON, D.C. (February 4, 2003) - The Biotechnology Industry Organization (BIO) will host its fifth annual CEO & Investor Conference February 25-27 at the Waldorf-Astoria in New York City. This... |
|
BIO Calls for Restoration of Medicare Drug CoverageJan 29 2003
Washington, D.C. (January 29, 2003) − Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement in response to remarks made by President... |
|
BIO Board Member and CEO of Alkermes Richard F. Pops, To Testify On Medicare IssuesJan 29 2003
WASHINGTON, D.C. (January 29, 2003) – Richard F. Pops, CEO of Alkermes, Inc., and vice-chair of healthcare for the Biotechnology Industry Organization’s (BIO) Board of Directors, will... |
